Rekombinanter ALDH2 Antikörper

Produktnummer ABIN7879942

Der Kaninchen Monoklonal anti-ALDH2 Antikörper (Klon 31A72) (ABIN7879942) detektiert spezifisch ALDH2 in WB. Dieser Antikörper reagiert spezifisch mit Proben aus Human, Ratte und Maus.

Kurzübersicht für Rekombinanter ALDH2 Antikörper (ABIN7879942)

Target: ALDH2 (Aldehyde Dehydrogenase 2 Family (Mitochondrial) (ALDH2))

Antikörpertyp: Recombinant Antibody

Reaktivität: Human, Ratte, Maus

Wirt: Kaninchen

Klonalität: Monoklonal

Konjugat: Dieser ALDH2 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Klon: 31A72

Produktdetails anti-ALDH2 Antikörper

Verwendungszweck: ALDH2 Antibody / Aldehyde dehydrogenase 2

Aufreinigung: Affinity-chromatography

Immunogen: A synthesized peptide derived from human ALDH2 was used as the immunogen for the ALDH2 antibody.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Optimal dilution of the ALDH2 antibody should be determined by the researcher.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Rabbit IgG in phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol, 0.4-0.5 mg/mL BSA

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store the ALDH2 antibody at -20oC.

Details zu ALDH2

Target: ALDH2 (Aldehyde Dehydrogenase 2 Family (Mitochondrial) (ALDH2))

Andere Bezeichnung: ALDH2

Hintergrund: ALDH2 antibody detects aldehyde dehydrogenase 2, a mitochondrial enzyme that catalyzes the oxidation of acetaldehyde and other toxic aldehydes into less reactive carboxylic acids. ALDH2 belongs to the aldehyde dehydrogenase superfamily and is highly expressed in liver, heart, and skeletal muscle. It plays a crucial role in alcohol metabolism, detoxification of lipid peroxidation products, and protection against oxidative stress.

Research using ALDH2 antibody has revealed the enzyme's central importance in human health. ALDH2 metabolizes acetaldehyde generated during ethanol metabolism, preventing toxic accumulation that causes alcohol flushing and tissue damage. A common polymorphism, ALDH2*2, prevalent in East Asian populations, reduces enzymatic activity and leads to heightened acetaldehyde sensitivity. This variant is associated with increased risk of esophageal cancer, cardiovascular disease, and alcohol intolerance.

Beyond alcohol metabolism, ALDH2 detoxifies reactive aldehydes such as 4-hydroxynonenal (4-HNE) and malondialdehyde, protecting cells from oxidative damage. Reduced ALDH2 activity increases susceptibility to ischemic injury, neurodegeneration, and metabolic disorders. In cardiovascular research, ALDH2 has been shown to protect against myocardial infarction and heart failure by detoxifying aldehydes generated during ischemic stress. Pharmacological activation of ALDH2 has been investigated as a therapeutic strategy for cardiovascular protection.

In cancer research, altered ALDH2 expression contributes to tumor progression and therapy response. High ALDH activity, often considered a stem cell marker, confers chemoresistance and supports cancer stem cell survival. ALDH2 also intersects with mitochondrial metabolism, influencing cellular redox states and survival pathways.

Antibodies against ALDH2 are validated for western blot, immunohistochemistry, immunofluorescence, and ELISA. These reagents enable detection of mitochondrial localization, quantification of expression, and monitoring of activity under stress conditions. They provide tools for studying alcohol-related disease, cardiovascular protection, and cancer biology.

NSJ Bioreagents provides this ALDH2 antibody for studies in metabolism, toxicology, and mitochondrial biology.

UniProt: P05091